These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 39304808)
1. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity. Akorli J; Opoku M; Appiah-Twum F; Akpo MS; Ismail RY; Boamah GYK; Obeng-Aboagye E; Adu-Asamoah D; Donkor IO BMC Infect Dis; 2024 Sep; 24(1):1020. PubMed ID: 39304808 [TBL] [Abstract][Full Text] [Related]
2. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients. Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of oropharyngeal microbiota in healthcare workers post-COVID-19. Wei Y; Yu W; Zhang Z; Liu S; Xue J; Wu C; Gao Z; Guo S Front Cell Infect Microbiol; 2024; 14():1347345. PubMed ID: 38828262 [TBL] [Abstract][Full Text] [Related]
5. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896 [TBL] [Abstract][Full Text] [Related]
7. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities. Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102 [TBL] [Abstract][Full Text] [Related]
8. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies. Kullberg RFJ; Wikki I; Haak BW; Kauko A; Galenkamp H; Peters-Sengers H; Butler JM; Havulinna AS; Palmu J; McDonald D; Benchraka C; Abdel-Aziz MI; Prins M; Maitland van der Zee AH; van den Born BJ; Jousilahti P; de Vos WM; Salomaa V; Knight R; Lahti L; Nieuwdorp M; Niiranen T; Wiersinga WJ Lancet Microbe; 2024 Sep; 5(9):100864. PubMed ID: 38909617 [TBL] [Abstract][Full Text] [Related]
10. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR Elife; 2021 Oct; 10():. PubMed ID: 34636722 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection. Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857 [TBL] [Abstract][Full Text] [Related]
13. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity. Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246 [TBL] [Abstract][Full Text] [Related]
14. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance. Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454 [TBL] [Abstract][Full Text] [Related]
15. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Ma S; Zhang F; Zhou F; Li H; Ge W; Gan R; Nie H; Li B; Wang Y; Wu M; Li D; Wang D; Wang Z; You Y; Huang Z Signal Transduct Target Ther; 2021 May; 6(1):191. PubMed ID: 33986253 [TBL] [Abstract][Full Text] [Related]
16. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences. Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423 [TBL] [Abstract][Full Text] [Related]
17. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19. Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058 [TBL] [Abstract][Full Text] [Related]
18. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19. Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448 [TBL] [Abstract][Full Text] [Related]
19. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults. Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047 [TBL] [Abstract][Full Text] [Related]
20. Microbial Composition of the Human Nasopharynx Varies According to Influenza Virus Type and Vaccination Status. Ding T; Song T; Zhou B; Geber A; Ma Y; Zhang L; Volk M; Kapadia SN; Jenkins SG; Salvatore M; Ghedin E mBio; 2019 Jul; 10(4):. PubMed ID: 31266874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]